A new classification system of anticancer drugs - based on cell biological mechanisms

Area of Science:

• Oncology
• Pharmacology
• Cell Biology

Background:

• Numerous novel anticancer agents necessitate a revised classification system.
• Existing classifications may not fully capture the complex mechanisms of action for new drugs.

Purpose of the Study:

• To establish a novel classification system for anticancer agents.
• To categorize drugs based on their underlying cell biological mechanisms.

Main Methods:

• Development of a classification system based on cell biological mechanisms.
• Grouping anticancer drugs into cytotoxic agents and modifiers.
• Subdividing modifiers into cell biological, biological response, and biochemical modulators.

Main Results:

• Anticancer drugs are classified as cytotoxic or modifiers.
• Modifiers are further categorized by their function: reversing tumor cell behavior, regulating host response, or altering drug metabolism.
• Combinations of cytotoxic drugs with modifiers offer enhanced therapeutic strategies.

Conclusions:

• The proposed classification system provides a framework for understanding diverse anticancer agent mechanisms.
• This system aids in optimizing combination therapies by clarifying drug interactions.
• It facilitates a better understanding of how drugs modulate tumor cells, host responses, and drug metabolism.